Table 3

Patient characteristics (thrombolytic treatment)

Thrombus locationEstimated thrombus ageThrombolytic agentDose administeredDuration of treatmentShort-term outcome
Unilateral femoral artery1 dayt-PA1.5 mg/kg/day2 daysComplete patency
Unilateral femoral artery3-150 ?t-PA0.5 mg/day3 daysComplete patency
External iliacal artery/abdominal aorta3 dayst-PA** 7.2 mg/kg/day9 hoursFailure
3.6 mg/kg/day3 days
Unialteral femoral artery3 daysUK4000 U/hour3 daysComplete patency
Unilateral brachial artery?t-PA 1.4 mg/kg/day10 daysComplete patency
Bilateral external iliacal arteriesConnatalt-PA−12 mg/kg/day30 daysPartial patency
  • t-PA: recombinant tissue type plasminogen activator; UK: urokinase.

  • 3-150 Associated with central line; ** bleeding from puncture sites; cross-over from UK.